iSpecimen (NASDAQ:ISPC) Stock Price Up 0.8% – What’s Next?

iSpecimen Inc. (NASDAQ:ISPC)’s share price shot up 0.8% during trading on Friday. The company traded as high as $0.8378 and last traded at $0.8142. 237,309 shares changed hands during mid-day trading, a decline of 10% from the average session volume of 263,632 shares. The stock had previously closed at $0.8079.

Analyst Ratings Changes

Separately, Weiss Ratings upgraded shares of iSpecimen from a “sell (e)” rating to a “sell (e+)” rating in a research report on Thursday, October 29th. One investment analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, iSpecimen has a consensus rating of “Sell”.

iSpecimen Price Performance

The company has a 50-day moving average of $1.15 and a two-hundred day moving average of $4.60. The stock has a market capitalization of $2.05 million, a PE ratio of -0.01 and a beta of 1.54.

iSpecimen (NASDAQ:ISPC) last released its earnings results on Friday, August 14th. The company reported ($0.98) earnings per share (EPS) for the quarter. iSpecimen had a negative return on equity of 524.39% and a negative net margin of 2,445.40%. The company had revenue of $0.15 million during the quarter.

iSpecimen Company Profile

iSpecimen, Inc (NASDAQ: ISPC) operates a technology-enabled marketplace that connects life sciences researchers with sources of human biospecimens. Its platform is designed to help pharmaceutical, biotechnology, diagnostic and academic organizations identify, search for and procure biological samples and associated clinical data for research and development.

The company’s offerings support access to a range of specimen types, including blood, tissue and other human-derived samples obtained through healthcare providers, laboratories, biobanks and research institutions.